Islay Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Islay Capital Management's PFE Position: Q2 2026 in Review
Islay Capital Management held its Pfizer (PFE) position steady in Q2 2026 at 200 shares worth $4.82K. The position accounts for ﹤0.01% of the portfolio, ranked #194.
Islay Capital Management first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $119K in Q4 2021. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Islay Capital Management held 200 shares of Pfizer worth $4.82K as of Q2 2026.
- Islay Capital Management left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up ﹤0.01% of Islay Capital Management's portfolio in Q2 2026, its #194 holding.
- Islay Capital Management first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
- Islay Capital Management's Pfizer position peaked at $119K in Q4 2021.
- 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Islay Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.